Hynek Mergental

16PUBLICATIONS
26CO-AUTHORS
Nanotoxicology, health and safetyMedical roboticsCell development, proliferation and deathMicrofluidics and nanofluidicsMetabolomic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 18, 2023
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes.

Hynek Mergental, Richard W Laing, Amanda J Kirkham

|Jun 06, 2022
In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death.

Kayvan Mohkam, David Nasralla, Hynek Mergental

|Sep 24, 2021
Is Hepatocyte Necrosis a Good Marker of Donor Liver Viability During Machine Perfusion?

Desley A H Neil, Hynek Mergental, Angus Hann

|Feb 13, 2021
Reply to 'Hypothermic machine perfusion before viability testing of previously discarded human livers'.

Hynek Mergental, Richard W Laing, Simon C Afford

|Oct 27, 2020
Lactate measurements in an integrated perfusion machine for human livers.

Barney T F Stephenson, Simon C Afford, Hynek Mergental

|Jun 18, 2020
Transplantation of discarded livers following viability testing with normothermic machine perfusion.

Hynek Mergental, Richard W Laing, Amanda J Kirkham

Pageof 3